News - Dermatologicals, Licensing


Current filters:


Popular Filters

1 to 25 of 28 results

Sandoz in deal to commercialize Anacor’s Kerydin in USA

Sandoz in deal to commercialize Anacor’s Kerydin in USA


USA-based Anacor Pharmaceuticals has entered into an exclusive agreement with Sandoz, a subsidiary of…

Anacor PharmaceuticalsBusiness FinanceDermatologicalsKerydinLicensingMajorNovartisOnychomycosisPharmaceuticalPharmaceutical industryPharmaDermSandozTopical solutionUSA

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech


Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

UCB and Dermira link up for Cimzia in dermatology

UCB and Dermira link up for Cimzia in dermatology


Belgium’s largest drugmaker UCB and Dermira, a privately held USA-based dermatology company, have entered…


KYTHERA regains rights to ATX-101 outside USA and Canada from Bayer

KYTHERA regains rights to ATX-101 outside USA and Canada from Bayer


US biotech firm KYTHERA Biopharmaceuticals says it has re-acquired all rights outside of the USA and…

ATX-101BayerDermatologicalsKYTHERA BiopharmaceuticalsLicensingNorth AmericaPharmaceutical

Allergan closes $65 million deal with Medytox

Allergan closes $65 million deal with Medytox


This week US drugmaker Allergan (NYSE: AGN) announced that it has closed a $65 million license agreement…


Royalty Pharma acquires additional interest in Tecfidera for $510 million

Royalty Pharma acquires additional interest in Tecfidera for $510 million


US private equity firm Royalty Pharma says that it has acquired an additional interest in the earn-out…

Biogen IdecDermatologicalsFumadermFumapharmLicensingNeurologicalPharmaceuticalRoyalty PharmaTecfidera

Kyowa Hakko and LEO Pharma partner on topical calcipotriol/betamethasone dipropionate in Japan


Japanese drugmaker Kyowa Hakko Kirin and Denmark’s privately-held dermatology specialist LEO Pharma…

Asia-PacificBetamethasone DipropionatecalcipotriolDermatologicalsKyowa Hakko KirinLEO PharmaLicensingMarkets & MarketingPharmaceutical

APR and Angelini partner on wound management product


Privately-held Italian drugmaker Angelini and Switzerland-based health care group Applied Pharma Research…

AmuphaseAngeliniApplied Pharma ResearchDermatologicalsEuropeLicensingNexodynPharmaceutical

Galapagos in deal with Biogen Idec for scleroderma research

Galapagos in deal with Biogen Idec for scleroderma research


Belgian biotech firm Galapagos says that a subsidiary has signed a three-year collaboration agreement…

Biogen IdecBiotechnologyDermatologicalsGalapagosLicensingResearch

Karo Bio gets first milestone in Pfizer collaboration


Under its collaboration with US pharma behemoth Pfizer (NYSE: PFE), Sweden's Karo Bio (STO: KARO) says…

Anti-Arthritics/RheumaticsDermatologicalsFinancialKaro BioLicensingNeurologicalPfizerPharmaceuticalResearch

NovaBiotics enters co-development agreement for Novexatin


Scotland-headquartered clinical-stage biotech firm NovaBiotics has entered into an exclusive agreement…

BiotechnologyDermatologicalsLicensingNovaBioticsNovexatinTaro Pharmaceuticals

Mayne Pharma signs up deals to market Subacap in Europe


Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Galen in upfront $4.5million deal with Novo Research for US rights for Synera pain relief patch


Canada's Nuvo Research (TSX: NRI) today (July 11) announced that its wholly owned subsidiary, ZARS Pharma,…

DermatologicalsGalen USLicensingNorth AmericaNuvo ResearchPharmaceuticalSyneraZARS Pharma

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial


Privately-held Spanish drugmaker Ferrer Internacional says that it has successfully completed a Phase…

Antibiotics and Infectious diseasesDermatologicalsFerrer InternacionalLicensingOzenoxacinPharmaceuticalResearch

LEO Pharma and 4SC Discovery link for skin disease research


Privately-held Danish dermatology specialist LEO Pharma has entered into an exclusive research and license…

4SC DiscoveryBiotechnologyDermatologicalsLEO PharmaLicensingPharmaceuticalResearch

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01


USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan's PharmaEssentia…

Asia-PacificBiotechnologyDermatologicalsKinex PharmaceuticalsKX01LicensingPharmaEssentia

Kyorin Pharma transfers Pekiron rights to Galderma


Japan's Kyorin Holdings (TYO: 4569), through its Kyorin Pharmaceuticals subsidiary, aiming to concentrate…

Asia-PacificDermatologicalsGaldermaKyorin PharmaceuticalsLicensingPekironPharmaceutical

Sinclair IS partners with Quintiles to commercialize portfolio in Mexico


UK-based Sinclair IS Pharma (AIM: SPH.L) yesterday announced the signing of a 10-year collaboration and…

DermatologicalsLicensingMarkets & MarketingPharmaceuticalQuintilesSinclair IS PharmaSouth America

Nuvo Research gets $6.0 million milestone on Pliaglis EU approvals


Canada-based specialty pharma firm Nuvo Research (TSX: NRI) announced that global commercial partner…

DermatologicalsEuropeFinancialGaldermaLicensingNuvo ResearchPharmaceuticalPliaglis

LEO Pharma seeks new partners to boost derma products pipeline


Privately-held Danish drugmaker LEO Pharma last week revealed that it is now actively searching for new…

DermatologicalsLEO PharmaLicensingPharmaceutical

GlaxoSmithKline gets global rights to Basilea's Toctino


UK pharma giant GlaxoSmithKline (LSE: GSK) says that its dermatology-focussed subsidiary Stiefel has…

Basilea PharmaceuticaceftobiproleDermatologicalsGlaxoSmithKlineisavuconazoleLicensingPharmaceuticalResearchStiefelToctino

Hi-Tech Pharmacal gains rights to the Cormax brand from Watson


Hi-Tech Pharmacal (Nasdaq: HITK) says it has signed a definitive agreement under which it has acquired…

CormaxDermatologicalsGenericsHi-Tech PharmacalLicensingWatson Pharmaceuticals

RegeneRx explores strategic options


US biotech firm RegeneRx Biopharmaceuticals. (OTC Bulletin Board: RGRX) revealed yesterday that it has…


1 to 25 of 28 results

Back to top